The Executive Committee supports the Board of Directors by advising on decision-making processes, handling time-sensitive issues, and overseeing organizational policies, human resources, external relations, and strategic planning, with the authority to act on the Board's behalf within defined limitations.
Chair: Bruce Strober, United States, President
Members
Claudia de la Cruz, Chile, Vice President/President-Elect
Joel Gelfand, United States, Treasurer
Catherine Smith, United Kingdom, Secretary
Christy Langan, United States, CEO
The Finance Committee is tasked with overseeing the organization's financial health, ensuring the maintenance of accurate financial records, preparation of meaningful financial statements, budget oversight, asset protection, and compliance with financial regulations.
Chair: Joel Gelfand, USA, Treasurer
Members
Bruce Strober, United States, President
Andrew Blauvelt, United States
Lone Skov, Denmark
Christy Langan, United States, CEO
The Governance Committee evaluates and refines the organization's governance structures and practices, ensuring the Board's composition meets its diverse needs for effective duty fulfillment. Responsibilities include overseeing Board Member elections, assessing Board composition for diversity and expertise, developing governance policies, and ensuring consistency across the organization's mission, vision, and governing documents.
Chair: Catherine Smith, United Kingdom, Secretary
Members
Mahira El Sayed, Egypt
Johann Gudjonsson, United States
Bruce Strober, United States, President
Lluís Puig, Spain
Christy Langan, United States, CEO
The Membership Committee aims to enhance IPC's engagement by developing strategies to involve young professionals and underrepresented regions, and by creating platforms for members to collaborate and share information on their psoriasis-related projects.
Chair: André Carvalho, Brazil
Co-Chair: Olusola Ayanlowo, Nigeria
Members
Sunil Dogra, India
Peter Foley, Australia
Maria Angeliki Gkini, United Kingdom
Jason Hawkes, United States
Seong-Jin Jo, Republic of Korea
Azura Mohd Affandi, Malaysia
Established in 2026, the Africa Working Group brings together IPC members from across the continent to advance psoriasis care in Africa. The group provides a forum for experts to share knowledge, strengthen regional partnerships, and identify challenges affecting psoriasis patients and health care professionals. Its work supports locally relevant research and education while promoting greater awareness and improved standards of care throughout the region.
Chair: Mahira El Sayed, Egypt
Co-chair: Priscilla Angwenyi, Kenya
Members
Yemsrach Abawaji, Ethiopia (Fellow)
Nawaf Al-Mutairi, Kuwait
Marwa Amer, Egypt
Olusola Ayanlowo, Nigeria
Ashar Dhana, South Africa
Ncoza Dlova, South Africa
Nejib Doss, Tunisia
Dina ElDisouki, Egypt
Mona El-Kalioby, Egypt
Mohamed El-Komy, Egypt
Netsanet Gebeyehu, Ethiopia
Pierre Celestin Habiyaremye, PsorAfrica, Rwanda
Tshepang Mabala, South Africa (Fellow)
Doriane Sabushimike, Burundi
Gail Todd, South Africa
The Asia-Pacific Working Group, established in 2026, comprises all IPC members from the Asia-Pacific region, representing more than 50 experts. The group focuses on fostering regional collaboration, research, and education to address the diverse needs and challenges of psoriasis patients and health care professionals across the Asia-Pacific region. A Steering Committee, listed below, helps guide the working group's priorities and activities.
Steering Committee
Chair: Siew Eng Choon, Malaysia
Co-chair: Akimichi Morita, Japan
Members
Peter Foley, Australia
Chih-Hung Lee, Taiwan
Shekhar Neema, India
Hazel Oon, Singapore
Victoria Patiño-Guillano, Philippines
Yuling Shi, China
Established in 2026, the IPC Comorbidities Initiative brings together IPC members to advance the understanding and management of conditions that commonly occur alongside psoriasis. Working across three areas - Psoriatic Arthritis, Cardiovascular/Metabolic Health, and Mental Health - the initiative supports dermatologists in providing comprehensive care for patients living with psoriasis.
Chair: Joel Gelfand, United States
Co-Chair: Álvaro González-Cantero, Spain
Steering Committee Members
Joel Gelfand, United States
Álvaro González-Cantero, Spain
Saakshi Khattri, United States
Paolo Gisondi, Italy
Michael Garshick, United States
Mio Nakamura, United States
Marcus Schmitt-Egenolf, Sweden
Psoriatic Arthritis Workstream Members
Saakshi Khattri, United States (Lead)
Paolo Gisondi, Italy (Lead)
Arnon Cohen, Israel
Steve Fakharzadeh, United States
Jan Hugo, Czech Republic
Arthur Kavanaugh, United States
Anna López-Ferrer, Spain
Shekhar Neema, India
Towhida Noor, Bangladesh
Lev Pavlovsky, Israel
André Ribeiro, Brazil
Rodrigo Salinas, Argentina
Yuling Shi, China
Cardiovascular/Metabolic Workstream Members
Álvaro González-Cantero, Spain (Lead)
Michael Garshick, United States (Lead)
Romina Contreras, Paraguay
Anthony Fernandez, United States
Peter Foley, Australia
Wilson Liao, United States
Nehal Mehta, United States
Natalia Merino, Peru
Mohamad Mowla, Bangladesh
Hazel Oon, Singapore
Andreas Pinter, Germany
Ravi Ramessur, United Kingdom
Filip Rob, Czech Republic
Annika Smith, Australia
Maria Suárez, Brazil
Tiago Torres, Portugal
Alex Tsoi, United States
Yi Xiao, China
Mental Health Workstream Members
Marcus Schmitt-Egenolf, Sweden (Lead)
Mio Nakamura, United States (Lead)
Nicholas Brownstone, United States
Rudi Chandra, Indonesia
Jeff Cohen, United States
Ralph da Rosa, Brazil
Maria-Angeliki Gkini, United Kingdom
Elise Kleyn, United Kingdom
Paula Luna, Argentina
Ruth Murphy, United Kingdom
Doriane Sabushimike, Burundi
Dharshini Sathishkumar, India
George-Sorin Tiplica, Romania
Sofia Lovi, Malaysia (patient advocate)
Sertan Tiryaki, Turkey (patient advocate)
The Digital Health Working Group aims to enhance psoriasis care by developing and promoting best practices for using innovative digital technologies to educate practitioners, improve patient outcomes, and increase operational efficiency.
Chair: Andrew Blauvelt, United States
Co-chair: George Han, United States
Members
Daniela Armijo, Chile
Kevin Cooper, United States
Lucas Galimany, Chile
Netsanet Gebeyehu, Ethiopia
Paolo Gisondi, Italy
Mohammad Huq, Bangladesh
Satveer Mahil, United Kingdom
Alexander Navarini, Switzerland
Lev Pavlovsky, Israel
Dharshini Sathishkumar, India
Ron Vender, Canada
The Disease Severity Working Group focuses on standardizing the assessment of psoriasis severity through expert collaboration, aiming to improve diagnostic accuracy, treatment approaches, and patient care by developing metrics consistent across clinical and research environments.
Chair: Lone Skov, Denmark
Co-chair: Tiago Torres, Portugal
Members
Pravit Asawanonda, Thailand
Andrew Blauvelt, United States
Álvaro González-Cantero, Spain
Rudi Chandra, Indonesia
Cesar González, Colombia
Benjamin Hidalgo Matlock, Costa Rica
Julia-Tatjana Maul, Switzerland
Filip Rob, Czech Republic
The Diverse Skin Tones Working Group focuses on addressing the unique dermatological needs and challenges of individuals with diverse skin affected by psoriasis, aiming to enhance diagnostic and treatment capabilities and collaborating on related activities with various dermatology and patient associations.
Chair: Mahira El Sayed, Egypt
Co-chair: Murlidhar Rajagopalan, India
Members
Andrew Alexis, United States
Marwa Amer, Egypt
Nejib Doss, Tunisia
Maria-Angeliki Gkini, United Kingdom
Chris Griffiths, United Kingdom
Elise Kleyn, United Kingdom
Mark Lebwohl, United States
Angela Londoño, Colombia
Nelson Mosha, Tanzania
Mohammad Rafiqul Mowla, Bangladesh
Mio Nakamura, United States
Junko Takeshita, United States
Vermén Verallo-Rowell, Philippines
The IPC Early Career Steering Committee supports the Early Career Membership and the IPC Junior Councilor Programs. The committee ensures both efforts are aligned with IPC’s mission and provide meaningful engagement, education, collaboration, and professional development opportunities for early-career individuals interested in psoriasis.
Chair: Maria-Angeliki Gkini, United Kingdom
Co-chair: Fernando Valenzuela, Chile
Members
Deepak Balak, Netherlands
Nicholas Brownstone, United States
Netsanet Gebeyehu, Ethiopia
Bryan Guevara, Philippines
Natalia Merino, Peru
Rebecca Nguyen, Australia
Josep Riera-Monroig, Spain
Jensen Yeung, Canada
The Editorial Committee oversees the creation and curation of medical and scientific content for IPC's digital platforms, ensuring high editorial standards and contributing to various publications, including regular commentaries on topical issues in the field.
Chair: Lluís Puig, Spain
Co-chair: Jason Hawkes, United States
Members
José-Manuel Carrascosa, Spain
Chayada Chaiyabutr, Thailand
Francis Lai, Australia
Leandro Leite, Brazil
Matías Maskin, Argentina
Juul van den Reek, Netherlands
Matthew Vesely, United States
The Fellowship Advisory Committee aligns IPC's Fellowship program with its strategic goals, providing oversight on curriculum planning, application review, and alumni engagement to enhance program outcomes and maintain continuous improvement.
Chair: Joel Gelfand, United States
Co-Chair: Cristina Echeverría, Argentina
Members
Priscilla Angwenyi, Kenya
Daniela Armijo, Chile
Cristina Echeverría, Argentina
Wilson Liao, United States
Andrew Pink, United Kingdom
Patricia Tinio, Philippines
Fernando Valenzuela, Chile
The Generalized Pustular Psoriasis (GPP) Working Group is dedicated to improving the recognition, diagnosis, and management of GPP worldwide through collaboration, education, and expert-driven initiatives.
Chair: Akimichi Morita, Japan
Co-chair: Ricardo Romiti, Brazil
Members
Azura Affandi, Malaysia
Malin Assarsson, Sweden
Mohamed El-Komy, Egypt
Julia Yu-Huei Huang, Taiwan
Renata Magalhães, Brazil
Julia-Tatjana Maul, Switzerland
Adam Reich, Poland
James Song, United States
Yayoi Tada, Japan
The Guidelines Task Force is dedicated to conducting a global needs assessment to understand and improve the development and use of psoriasis treatment guidelines, culminating in actionable recommendations for IPC implementation.
Chair: Catherine Smith, United Kingdom
Co-chair: Alexander Nast, Germany
Members
André Carvalho, Brazil
Colby Evans, United States
Kathleen Gallant, IFPA, United States
The multi-phase consensus process is led jointly by IPC and GRAPPA. It includes a global Steering Committee and Working Group, bringing together dermatology and rheumatology perspectives along with patient input to establish clear definitions, address gaps in terminology, and identify research and clinical management priorities. The key output will be consensus definitions for difficult-to-treat and treatment-refractory psoriasis..
Chair: Lone Skov, Denmark
IPC Steering Committee Members
Manuel Franco, Colombia
George Han, United States
Josep Riera-Monroig, Spain
Yuling Shi, China
IPC Working Group Members
Marwa Amer, Egypt
Deepak Balak, Netherlands
Mohammad Samiul Huq, Bangladesh
Jo Lambert, Belgium
Leandro Leite, Brazil
Wilson Liao, United States
Angela Londono-Garcia, Colombia
Jennifer Lavina Ngo, Philippines
Ronald Vender, Canada
Claus Zachariae, Denmark
Learn more about this initiative.
The Emerging Infectious Diseases Task Force actively monitors and addresses the impact of infectious diseases on psoriasis treatment and management, updating IPC guidelines and formulating responses to emergent issues as necessary.
Chair: Joel Gelfand, United States
Members
André Carvalho, Brazil
Hervé Bachelez, France
Mahira El Sayed, Egypt
Lluís Puig, Spain
Catherine Smith, United Kingdom
The Latin American Working Group, established in 2011, focuses on fostering collaboration, research, and advocacy to address the unique needs and challenges of psoriasis patients and health care professionals in Latin America, particularly tackling issues like limited healthcare resources and access to biologics through symposia and publications on significant clinical topics.
Chair: André Carvalho, Brazil
Chair: Claudia de la Cruz, Chile
Co-chair: Fernando Valenzuela, Chile
Members
Daniela Armijo, Chile
Jaquelini Barboza da Silva, Brazil
Juan Raul Castro Ayarza, Colombia
Paola Cardeñas, Colombia
Sonia Chavez-Alvarez, Mexico
Edgardo Chouela, Argentina
Romina Contreras, Paraguay
María Julia Cura, Argentina
Cristina Echeverría, Argentina
Manuel Franco, Colombia
Lucas Galimany, Chile
Rodrigo Garcia Salinas, Argentina
César Gonzalez, Colombia
Benjamin Hidalgo Matlock, Costa Rica
Leandro Leite, Brazil
Angela Londoño, Colombia
Renata Magalhães, Brazil
Matías Maskin, Argentina
Natalia Merino, Peru
Nancy Podoswa, Mexico
Ricardo Romiti, Brazil
Andre Ribeiro, Brazil
Enrique Rivas, Guatemala
Maria Victoria Suarez Restrepo, Brazil
Margarita Velásquez, Colombia
Ralph Vighi da Rosa, Brazil
The Palmoplantar Pustulosis (PPP) Working Group is focused on addressing the unique challenges of PPP by fostering international collaboration, advancing clinical knowledge, and promoting improved care for patients affected by the disease.
Chair: Siew Eng Choon, Malaysia
Co-Chair: Seong Jin Jo, Republic of Korea
Members
Robert Bissonnette, Canada
Francesca Capon, Canada
José Manuel Carrascosa-Carrillo, Spain
Maria Julia Cura, Argentina
Wilson Liao, United States
Mari Løset, Norway
Xiao-Yong Man, China
Masamoto Murakami, Japan
Ulrich Mrowietz, Germany
Yukari Okubo, Japan
Shuai Shao, China
Margarita Velásquez, Colombia
The Pediatric Psoriasis Working Group is established to identify, prioritize, and address key gaps in diagnosing, treating, managing, and understanding psoriasis in children and adolescents.
Chair: Amy Paller, United States
Co-Chair: Marieke Seyger, Netherlands
Members
Cristina Bertoli, Italy
Kelly Cordoro, United States
Mona El-Kalioby, Egypt
Paula Luna, Argentina
Renata Magalhaes, Brazil
Emmanuel Mahé, France
Ruth Murphy, United Kingdom
Towhida Noor, Bangladesh
Vimal Prajapati, Canada
Enrique Rivas, Guatemala
Dharshini Sathishkumar, India
Raquel Vaz, Sweden, IFPA Representative
Marijana Vičić, Croatia
Lara Wine Lee, United States
The Research Committee will drive IPC's research goals by developing new programs to enhance researcher representation and create virtual collaboration opportunities to facilitate knowledge exchange within the network.
Chair: Johann Gudjonsson, United States
Co-chair: Nicole Ward, United States
Members
Hervé Bachelez, France
Curdin Conrad, Switzerland
Elke de Jong, Netherlands
María Julia Cura, Argentina
Albert Duvetorp, Sweden
Antonios Kolios, Switzerland
Chih-Hung Lee, Taiwan
Yukari Okubo, Japan
Hazel Oon, Singapore
Alison Treichel, United States
Margarita Velásquez, Colombia
The Symposia Committee oversees the strategic planning and quality of IPC symposia at global congresses, ensuring alignment with organizational goals and delivering high-quality content on the latest advancements in psoriasis research and care to health care professionals.
Chair: Johann Gudjonsson, United States
Co-chair: Jo Lambert, Belgium
Members
Ashar Dhana, South Africa
Cristina Echeverría, Argentina
Satveer Mahil, United Kingdom
Akimichi Morita, Japan
Shekhar Neema, India
Alex Tsoi, United States
Lily Lyralin Tumalad
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.
